Concepedia

LiuLiang Qin

LQ

19

Publications

2.1K

Citations

17

H-Index

2000

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Mersana Therapeutics (United States)

Center for Vascular Biology Research

Huazhong University of Science and Technology

LiuLiang Qin is an author at Beth Israel Deaconess Medical Center specializing in medicine, immunotherapy, and pharmacology.

ORCID

Top concepts

Publications per year

2000–2023

19

Publications

19

Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

Akin Akinc, William Querbes, Soma De et al. · Molecular Therapy · 2010 · 1.1K citations · Full text

, , +17

Orphan nuclear receptor TR3/Nur77 regulates VEGF-A–induced angiogenesis through its transcriptional activity

Huiyan Zeng, LiuLiang Qin, Dezheng Zhao et al. · The Journal of Experimental Medicine · 2006 · 162 citations · Full text

The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1

LiuLiang Qin, Dezheng Zhao, Jianfeng Xu et al. · Blood · 2013 · 104 citations · Full text

A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy

Alexander V. Yurkovetskiy, Mao Yin, Natalya D. Bodyak et al. · Cancer Research · 2015 · 99 citations

, , +20

Down Syndrome Candidate Region 1 Isoform 1 Mediates Angiogenesis through the Calcineurin-NFAT Pathway

LiuLiang Qin, Dezheng Zhao, Xin Liu et al. · Molecular Cancer Research · 2006 · 82 citations · Full text

Rows per page

1–5 of 19